Image - 10 February 2022

coronavirus.enzyme.jpg

License:: Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
File format:: .jpg
Size:: 1920 x 1080, 500 KB

Download

Topics

Contacts

Elin Bäckström

Press contact Press Officer Research Education elin.backstrom@uu.se +46-70-425 09 83

Linda Koffmar

Press contact Press Officer linda.koffmar@uu.se +46 (0)18-471 19 59

Sandra Gunnarsson

Press contact Press Officer sandra.gunnarsson@uu.se +4673 469 75 92

Promising molecule for treatment of COVID-19

Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19. The molecule is effective against both the new variant and previously identified coronaviruses. The article has been published in the Journal of the American Chemical Society.

Uppsala University - quality, knowledge, and creativity since 1477

Founded in 1477, Uppsala University is the oldest university in Sweden. With more than 50,000 students and 7,500 employees in Uppsala and Visby, we are a broad university with research in social sciences, humanities, technology, natural sciences, medicine and pharmacology. Our mission is to conduct education and research of the highest quality and relevance to society on a long-term basis. Uppsala University is regularly ranked among the world’s top universities.